Section 1

Preview this deck

Sitagliptin phoshphate (Januvia)

Front

Star 0%
Star 0%
Star 0%
Star 0%
Star 0%

0.0

0 reviews

5
0
4
0
3
0
2
0
1
0

Active users

0

All-time users

0

Favorites

0

Last updated

6 years ago

Date created

Mar 1, 2020

Cards (19)

Section 1

(19 cards)

Sitagliptin phoshphate (Januvia)

Front

monotherapy for type 2, prolongs natural incretins, increasing insulin and lowering glucagon, modify dose in renal failure

Back

Becaplermin (Regranex)

Front

topical gel, platelet growth factor, for lower extremity diabetic neuropathic ulcers w/ adequate blood supply

Back

Linagliptin (Tradjenta)

Front

DPP-4 inhibitor, prolong incretins, not for type 1, lower dose of sulfonylurea w/ this drug

Back

Ertugliflozin (Steglatro)

Front

SGLT2 inhibitor, block glucose reabsorption in kidney, UTI and vaginal yeast infection side effect

Back

Pioglitazone, Glimepiride (Duetact)

Front

p targets insulin resistance, g increases insulin production from pancreas, complementary actions

Back

Albiglutide (Tanzeum)

Front

weekly injection, better control, 2 copies of GLP-1 bound to albumin, risk of thyroid c-cell tumors

Back

Semaglutide (Ozempic)

Front

GLP-1 agonist

Back

Canagliflozin (Invokana)

Front

blocks glucose reabsorption in the kidney, discontinue if GFR falls below 45ml/min/1.73 m2

Back

Exenatide (Byetta)

Front

incretin mimetic, GLP-1 (glucagon) agonist, causing insulin synthesis and excretion, from lizard spit

Back

Bromocriptine (Cycloset)

Front

dopamine receptor agonist, reset bio clock, improves metabolism problems related to diabetes, w/ food

Back

Colesevelam (Welchol)

Front

bile acid sequestrant, for type 2

Back

Dulaglutide (Trulicity)

Front

GLP-1 agonist, decreases glucagon, slows gastric emptying

Back

Empagliflozin (Jardiance)

Front

SGLT2 inhibitor, block glucose reabsorption in kidney, UTI and vaginal yeast infection side effect

Back

Alogliptin (Nesina)

Front

DPP-4 inhibitor, prolong incretins, adverse effects anaphylaxis, angioedema, fatal hepatic failure

Back

Victoza (liraglutide)

Front

incretin mimetic, GLP-1 receptor agonist, adjunct to diet and excercise

Back

Dapagliflozin (Farxiga)

Front

blocks glucose reabsorption in kidney, side effect UTI, vaginal yeast infection

Back

Lixisenatide (Adlyxin)

Front

GLP-1 agonist, increase insulin release, decrease glucagon, slow gastric emptying

Back

Pramlintide acetate (Symlin)

Front

synthetic analog of amylin, contributes to glucose control after meals

Back

Saxagliptin (Onglyza)

Front

Dpp-4 inhibitor, prolong incretins, adverse effects low WBC, hives, pancreatitis, headaches, hypoglycemia

Back